International
Director of Lululemon Purchases Shares After Large Drop – Insider Weekends
Key Insights:
Lululemon Athletica (NASDAQ: LULU) is one of the more popular athletic apparel brands that sells clothing for yoga, running, training, and…
Key Insights:
- Lululemon Athletica (NASDAQ: LULU) is one of the more popular athletic apparel brands that sells clothing for yoga, running, training, and other activities.
- The company recently saw a big dip in stock price after full-year guidance fell short of analyst and consensus estimates, though this could be an opportunity for investors.
- Lululemon has grown greatly over the last few years and quarters, and also had a very strong fiscal 2023 – with net revenue for the year increasing by 19% to $9.6 billion.
- The company boasts attractive margins (a gross profit margin of 58.31% and a net income margin of 16.12% trumping many competitors) and maintains a strong balance sheet with cash and cash equivalents of $2.2 billion and total liabilities of $2.86 billion ($1.15 billion of which are capital leases)
- Following this drop in stock price, Chair of the Board Martha Morfitt (who has served on the board since 2008) purchased shares for the first time since 2021
Lululemon Athletica Inc. (LULU): $390.65
Market Cap: $49.23B
Enterprise Value: $48.38B
Lululemon Athletica (LULU) is one of the more popular athletic apparel brands that sells clothing for yoga, running, training, and other activities. Lululemon has taken the higher-end athleisure market by storm and investors have reacted enthusiastically – driving the stock price up by over 60% in 2023.
The Canadian company was founded in 1998 as a manufacturer of women's yoga pants, but has largely expanded its product offerings to various forms of apparel, accessories, and personal care products. With 711 stores across the globe, Lululemon is focused on global expansion while maintaining their high quality of goods – opening 25 net new stores during the fourth quarter of 2023. Thirteen of these stores were opened in mainland China, 7 in the US, and 5 others in the rest of the world.
Lululemon Growth
The company had a strong fiscal 2023 (ended January 28, 2024), with net revenue for the year increasing by 19% to $9.6 billion (compared to fiscal 2022). Comparable sales also increased by 13% – with mainland China comparable sales increasing by 39%, Americas comparable sales increasing by 8%, and the rest of the world comparable sales increasing by 32%. Gross profit increased by 25% to a strong $5.6 billion and net income grew by 81.4 % to $1.55 billion. In fiscal 2023, the company also announced a partnership with the exercise machinery company Peloton Inc. (NASDAQ: PTON), becoming their primary apparel provider.
Lululemon's Revenue Breakdown by Region
Lululemon also has relatively strong margins compared to its competitors – a gross profit margin of 58.31% and a net income margin of 16.12% trumps similar athletic apparel companies like Nike Inc. (NYSE: NKE), which has a gross profit and net income margins of 44.30% and 10.14% respectively. The company's balance sheet is also fairly attractive, with total inventories in Q4 2023 decreasing 9% to $1.3 billion compared to Q4 2022 – a good sign, especially considering that the fourth quarter of the year is typically when retailers end up with excess inventory after ramping up for the holidays. Cash and cash equivalents were also $2.2 billion at the end of Q4 2023, which is especially attractive considering total liabilities are $2.86 billion – $1.15 billion of which are capital leases.
Despite these strong results, the company took a hit in recent weeks after full-year guidance fell below analyst and investor expectations. The company expected Q1 2024 revenue to fall between $2.18 billion to $2.20 billion, versus the $2.26 billion consensus and full-year revenue to be between $10.7 billion and $10.8 billion, as opposed to the $11 billion consensus. This dip in stock price is likely what convinced Chair of the Board Martha Morfitt to purchase shares.
The last time Ms. Morfitt purchased shares was in June 2021, when the stock was trading at roughly $330 a share. Since then, the stock price has seen a high of over $500 (at which point many insiders of the company, such as the CFO, CEO, and Chief Brand Officer, began to sell shares) but Ms. Morfitt only purchased shares once more when the stock price settled back at roughly $389 a share.
We always like to see purchases by insiders that have been with a company for a long period of time and Ms. Morfitt has served on Lululemon's board since December 2008, observing the company operate through the Great Recession and the pandemic. Ms. Morfitt also serves as a principal of River Rock Partners, a business and cultural transformation consulting firm, and is a Director of the fluid handling systems and components company Graco Inc. (NYSE: GGG) and the haircare company Olaplex Inc. (NASDAQ: OLPX).
The recent dip in Lululemon's stock price has made the company fairly attractive to us, although it does remain expensive with a P/E of 32.02. Despite the guidance not meeting consensus estimates, the company still expects growth over the next few quarters and years, and if they can maintain their favorable margins and balance sheet, the company is well positioned for the future. While we won't start a position in the company immediately, we may revisit it for an upcoming mid-month or monthly newsletter idea.
Editor's Note: Tamanna Suria contributed to this article.
Welcome to edition 727 of Insider Weekends. Insider buying increased last week; with insiders purchasing $110.06 million of stock compared to $74.12 million in the week prior. Selling declined sharply to $ 1.94 billion compared to $3.29 billion in the week prior.
Sell/Buy Ratio: The Insider Sell/Buy ratio is calculated by dividing the total insider sales in a given week by the total insider purchases that week. The adjusted ratio dropped notably to 17.65 . In other words, insiders sold almost 18 times as much stock as they purchased. This week again the Sell/Buy ratio was favorable; compared to the prior week when the ratio stood at 44.5.
Notable Insider Buys:
1. Snowflake Inc. (NYSE: SNOW): $161.6
Chief Executive Officer Sridhar Ramaswamy acquired 31,542 shares of this cloud-based data warehousing company, paying $158.52 per share for a total amount of $5.00 million.
While not revealed in the Form 4 filing, as you can see from the second page of his employment agreement, the new CEO of Snowflake will receive an additional RSU grant of $5 million if he purchases $5 million worth of stock in the open market.
P/E: N/A | Forward P/E: 200 | Industry P/E: 28.95 |
P/S: 18.89 | Price/Book: 10.43 | EV/EBITDA: -51.75 |
Market Cap: $54.01B | Avg. Daily Volume: 7,138,344 | 52 Week Range: $135.26 – $237.72 |
2. Lululemon Athletica Inc. (LULU): $390.65
Director Martha A. Morfitt acquired 3,700 shares of this premium athletic apparel company, paying $389.05 per share for a total amount of $1.44 million.
P/E: 32.02 | Forward P/E: 27.62 | Industry P/E: 18.32 |
P/S: 5.16 | Price/Book: 11.63 | EV/EBITDA: 18.71 |
Market Cap: $49.23B | Avg. Daily Volume: 1,670,301 | 52 Week Range: $326.93 – $516.39 |
3. OmniAb Inc (NASDAQ: OABI): $5.42
President and CEO Matthew W. Foehr acquired 225,000 shares of this biotechnology company, paying $5.19 per share for a total amount of $1.17 million. Mr. Foehr increased his stake by 8.38% to 2,908,803 shares with this purchase.
P/E: N/A | Forward P/E: N/A | Industry P/E: 34.41 |
P/S: 15.81 | Price/Book: 2.02 | EV/EBITDA: -11.49 |
Market Cap: $634.82M | Avg. Daily Volume: 444,785 | 52 Week Range: $3.14 – $6.72 |
4. Grocery Outlet Holding Corp (NASDAQ: GO): $28.78
Director Erik D. Ragatz acquired 36,500 shares of this discount grocery retail chain, paying $28.25 per share for a total amount of $1.03 million.
P/E: 36.43 | Forward P/E: 24.45 | Industry P/E: 20.37 |
P/S: 0.73 | Price/Book: 2.34 | EV/EBITDA: 19.24 |
Market Cap: $2.86B | Avg. Daily Volume: 1,258,711 | 52 Week Range: $23.41 – $36.54 |
5. Summit Therapeutics Inc. (NASDAQ: SMMT): $4.14
Shares of this biopharmaceutical company were acquired by 2 insiders:
- Chief Executive Officer Mahkam Zanganeh acquired 110,321 shares, paying $3.73 per share for a total amount of $411,094. Mr. Zanganeh increased his stake by 0.44% to 24,923,800 shares with this purchase.
- Chief Financial Officer Ankur Dhingra acquired 100,000 shares, paying $3.75 per share for a total amount of $375,000.
P/E: N/A | Forward P/E: N/A | Industry P/E: 34.41 |
P/S: N/A | Price/Book: 37.39 | EV/EBITDA: -4.74 |
Market Cap: $2.91B | Avg. Daily Volume: 2,353,080 | 52 Week Range: $1.3 – $5.22 |
Notable Insider Sales:
1. Meta Platforms Inc. (NASDAQ: META): $485.58
Shares of Meta were sold by 3 insiders:
- COB and CEO Mark Zuckerberg sold 386,636 shares for $503.79, generating $194.78 million from the sale. A majority of these shares were sold through the Chan Zuckerberg Initiative Foundation.
- Chief Legal Officer Jennifer Newstead sold 585 shares for $505.29, generating $295,595 from the sale.
- Chief Operating Officer Javier Olivan sold 490 shares for $507.00, generating $248,430 from the sale.
P/E: 32.66 | Forward P/E: 24.15 | Industry P/E: 19.35 |
P/S: 9.46 | Price/Book: 8.08 | EV/EBITDA: 20.49 |
Market Cap: $1.24T | Avg. Daily Volume: 17,913,614 | 52 Week Range: $207.13 – $523.57 |
2. Autozone Inc. (NYSE: AZO): $3151.65
Executive Chairman William C. Rhodes sold 18,751 shares of this specialty automotive retail company for $3189.77, generating $59.81 million from the sale.
P/E: 22.24 | Forward P/E: 20.75 | Industry P/E: 18.32 |
P/S: 3.25 | Price/Book: N/A | EV/EBITDA: 15.71 |
Market Cap: $54.53B | Avg. Daily Volume: 161,670 | 52 Week Range: $2 – $3 |
3. Microstrategy Inc. (NASDAQ: MSTR): $1704.56
Executive Chairman Michael J. Saylor sold 25,000 shares of this business intelligence software company for $1776.62, generating $44.42 million from the sale.
P/E: 64.52 | Forward P/E: 1.25 | Industry P/E: 28.95 |
P/S: 56.9 | Price/Book: 13.36 | EV/EBITDA: -509.85 |
Market Cap: $28.92B | Avg. Daily Volume: 2,304,021 | 52 Week Range: $266 – $1 |
4. Arista Networks Inc. (NYSE: ANET): $289.98
President and CEO Jayshree Ullal sold 111,500 shares of this leading networking technology company for $299.70, generating $33.42 million from the sale.
P/E: 44.07 | Forward P/E: 38.76 | Industry P/E: 28.95 |
P/S: 15.69 | Price/Book: 12.56 | EV/EBITDA: 37.05 |
Market Cap: $90.66B | Avg. Daily Volume: 2,496,068 | 52 Week Range: $131.68 – $307.74 |
5. Salesforce Inc (NYSE: CRM): $301.18
Shares of this cloud-based software company were sold by 6 insiders:
- Chair and CEO Marc Benioff sold 75,000 shares for $304.61, generating $22.85 million from the sale.
- Co-Founder and CTO, Slack Parker Harris sold 5,142 shares for $306.31, generating $1.58 million from the sale. These shares were sold as a result of exercising options immediately prior to the sale.
- President and COO Brian Millham sold 3,342 shares for $306.47, generating $1.02 million from the sale.
- President and CFO Amy E. Weaver sold 942 shares for $305.46, generating $287,741 from the sale.
- Pres/Chief Engineering Officer Srinivas Tallapragada sold 942 shares for $305.46, generating $287,741 from the sale.
- EVP & Chief Accounting Officer Sundeep G. Reddy sold 66 shares for $305.46, generating $20,160 from the sale.
P/E: 71.71 | Forward P/E: 30.96 | Industry P/E: 28.95 |
P/S: 8.5 | Price/Book: 4.9 | EV/EBITDA: 29.18 |
Market Cap: $292.14B | Avg. Daily Volume: 5,766,177 | 52 Week Range: $187.31 – $318.71 |
SYMBOL | OWNER | RELATIONSHIP | DATE | COST | # SHARES | VALUE($) | TOTAL SHARES | FILING |
SNOW | Total Purchased by All Insiders: $5.00 million | |||||||
Ramaswamy Sridhar | Chief Executive Officer | Mar 25, 2024 | $158.52 | 31,542 | 5,000,038 | 31,542 | Mar 27, 04:14 PM | |
OABI | Total Purchased by All Insiders: $1.17 million | |||||||
FOEHR MATTHEW W | President and CEO | Mar 22, 2024 | $5.19 | 225,000 | 1,167,750 | 2,908,803 | Mar 25, 07:07 AM | |
BRT | Total Purchased by All Insiders: $827,582 | |||||||
GOULD JEFFREY | PRESIDENT AND CEO | Mar 27, 2024 | $16.05 | 3,300 | 52,949 | 3,551,173 | Mar 29, 04:20 PM | |
GOULD MATTHEW J | SENIOR VICE PRESIDENT | Mar 27, 2024 | $16.05 | 3,300 | 52,949 | 3,551,173 | Mar 29, 04:20 PM | |
GOULD JEFFREY | PRESIDENT AND CEO | Mar 26, 2024 | $16.14 | 11,200 | 180,753 | 3,547,873 | Mar 27, 04:20 PM | |
GOULD MATTHEW J | SENIOR VICE PRESIDENT | Mar 26, 2024 | $16.14 | 11,200 | 180,753 | 3,547,873 | Mar 27, 04:20 PM | |
GOULD JEFFREY | PRESIDENT AND CEO | Mar 25, 2024 | $16.48 | 4,275 | 70,443 | 3,536,673 | Mar 27, 04:20 PM | |
GOULD MATTHEW J | SENIOR VICE PRESIDENT | Mar 25, 2024 | $16.48 | 4,275 | 70,443 | 3,536,673 | Mar 27, 04:20 PM | |
GOULD JEFFREY | PRESIDENT AND CEO | Mar 22, 2024 | $16.26 | 3,471 | 56,450 | 3,532,398 | Mar 27, 04:20 PM | |
GOULD MATTHEW J | SENIOR VICE PRESIDENT | Mar 22, 2024 | $16.26 | 3,471 | 56,450 | 3,532,398 | Mar 27, 04:20 PM | |
GOULD JEFFREY | PRESIDENT AND CEO | Mar 19, 2024 | $16.25 | 991 | 16,105 | 3,528,927 | Mar 27, 04:20 PM | |
GOULD MATTHEW J | SENIOR VICE PRESIDENT | Mar 19, 2024 | $16.25 | 991 | 16,105 | 3,528,927 | Mar 27, 04:20 PM | |
GOULD JEFFREY | PRESIDENT AND CEO | Mar 18, 2024 | $16.29 | 2,277 | 37,091 | 3,527,936 | Mar 27, 04:20 PM | |
GOULD MATTHEW J | SENIOR VICE PRESIDENT | Mar 18, 2024 | $16.29 | 2,277 | 37,091 | 3,527,936 | Mar 27, 04:20 PM | |
SMMT | Total Purchased by All Insiders: $786,094 | |||||||
Zanganeh Mahkam | Chief Executive Officer | Mar 27, 2024 | $3.72 | 34,321 | 127,674 | 24,923,800 | Mar 27, 08:28 PM | |
Zanganeh Mahkam | Chief Executive Officer | Mar 27, 2024 | $3.71 | 20,000 | 74,200 | 50,000 | Mar 27, 08:28 PM | |
Zanganeh Mahkam | Chief Executive Officer | Mar 27, 2024 | $3.72 | 26,000 | 96,720 | 520,814 | Mar 27, 08:28 PM | |
Zanganeh Mahkam | Chief Executive Officer | Mar 26, 2024 | $3.75 | 30,000 | 112,500 | 30,000 | Mar 27, 08:28 PM | |
Dhingra Ankur | Chief Financial Officer | Mar 26, 2024 | $3.75 | 100,000 | 375,000 | 354,958 | Mar 27, 08:27 PM | |
PX | Total Purchased by All Insiders: $459,250 | |||||||
Jensen Richard J. | EVP, Head of Strategy and M&A | Mar 27, 2024 | $8.35 | 55,000 | 459,250 | 55,000 | Mar 28, 06:23 PM | |
EPSN | Total Purchased by All Insiders: $191,447 | |||||||
Stabell Jason | Chief Executive Officer | Mar 27, 2024 | $5.25 | 17,966 | 94,322 | 361,200 | Mar 28, 12:00 PM | |
Stabell Jason | Chief Executive Officer | Mar 26, 2024 | $5.25 | 18,500 | 97,125 | 343,234 | Mar 28, 12:00 PM | |
HROW | Total Purchased by All Insiders: $104,310 | |||||||
BAUM MARK L | CHIEF EXECUTIVE OFFICER | Mar 22, 2024 | $11.59 | 9,000 | 104,310 | 2,137,525 | Mar 25, 07:00 AM | |
WLKP | Total Purchased by All Insiders: $93,737 | |||||||
Kenner Andrew | SVP, Olefin Material & Corp Pr | Mar 21, 2024 | $22.16 | 4,230 | 93,737 | 145,839 | Mar 25, 10:17 AM | |
MG | Total Purchased by All Insiders: $90,000 | |||||||
Stamatakis Manuel N. | Interim President and CEO | Nov 7, 2023 | $6.00 | 15,000 | 90,000 | 233,599 | Mar 27, 04:16 PM | |
SGMT | Total Purchased by All Insiders: $63,731 | |||||||
Happel David | President & CEO | Mar 26, 2024 | $5.27 | 12,100 | 63,731 | 639,200 | Mar 28, 04:08 PM | |
RWAY | Total Purchased by All Insiders: $59,400 | |||||||
SPRENG R DAVID | President and CEO | Mar 21, 2024 | $11.88 | 5,000 | 59,400 | 64,532 | Mar 25, 06:33 PM | |
GLSI | Total Purchased by All Insiders: $49,950 | |||||||
Patel Snehal | CEO and CFO | Mar 22, 2024 | $19.98 | 2,500 | 49,950 | 5,347,777 | Mar 26, 06:05 AM | |
MIRM | Total Purchased by All Insiders: $49,600 | |||||||
BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | Mar 27, 2024 | $24.80 | 2,000 | 49,600 | 14,000 | Mar 27, 08:47 PM | |
DERM | Total Purchased by All Insiders: $34,790 | |||||||
Maraoui Claude | President & CEO | Mar 22, 2024 | $3.48 | 10,000 | 34,790 | 2,163,430 | Mar 25, 04:03 PM | |
HLF | Total Purchased by All Insiders: $25,835 | |||||||
Wang Henry C | EVP, General Counsel | Mar 26, 2024 | $9.30 | 2,778 | 25,835 | 176,194 | Mar 27, 07:31 PM | |
OCUP | Total Purchased by All Insiders: $25,100 | |||||||
SCHACHLE JOSEPH K | Chief Operating Officer | Mar 21, 2024 | $2.05 | 2,000 | 4,100 | 2,000 | Mar 25, 04:44 PM | |
Jhaveri Nirav S. | Chief Financial Officer | Mar 21, 2024 | $2.10 | 10,000 | 21,000 | 150,000 | Mar 25, 04:40 PM | |
CION | Total Purchased by All Insiders: $17,668 | |||||||
Gatto Mark | Co-Chairman & Co-CEO | Mar 27, 2024 | $11.02 | 50 | 551 | 50 | Mar 29, 10:55 AM | |
Gatto Mark | Co-Chairman & Co-CEO | Mar 27, 2024 | $11.02 | 50 | 551 | 50 | Mar 29, 10:55 AM | |
Gatto Mark | Co-Chairman & Co-CEO | Mar 27, 2024 | $11.02 | 50 | 551 | 50 | Mar 29, 10:55 AM | |
Gatto Mark | Co-Chairman & Co-CEO | Mar 27, 2024 | $11.02 | 1,000 | 11,020 | 1,000 | Mar 29, 10:55 AM | |
Reisner Michael A | Co-Chairman & Co-CEO | Mar 25, 2024 | $10.65 | 469 | 4,995 | 43,753 | Mar 26, 11:38 AM | |
COMM | Total Purchased by All Insiders: $14,500 | |||||||
Lorentzen Kyle David | EVP & CFO | Mar 27, 2024 | $1.25 | 11,600 | 14,500 | 712,475 | Mar 29, 03:06 PM | |
IMRX | Total Purchased by All Insiders: $14,024 | |||||||
Brakewood Harold Eugene | Chief Business Officer | Mar 22, 2024 | $2.57 | 3,900 | 10,015 | 3,900 | Mar 25, 09:10 AM | |
Morales Mallory | Chief Accounting Officer | Mar 22, 2024 | $2.55 | 393 | 1,000 | 8,278 | Mar 25, 09:04 AM | |
Morales Mallory | Chief Accounting Officer | Mar 21, 2024 | $2.72 | 1,107 | 3,009 | 7,885 | Mar 25, 09:04 AM | |
RVP | Total Purchased by All Insiders: $10,392 | |||||||
SHAW THOMAS J | PRESIDENT AND CEO | Mar 26, 2024 | $1.18 | 5,096 | 6,024 | 14,283,545 | Mar 27, 03:48 PM | |
SHAW THOMAS J | PRESIDENT AND CEO | Mar 25, 2024 | $1.21 | 3,612 | 4,368 | 14,278,449 | Mar 26, 11:33 AM | |
EDSA | Total Purchased by All Insiders: $10,000 | |||||||
Nijhawan Pardeep | Chief Executive Officer | Mar 25, 2024 | $4.00 | 2,500 | 10,000 | 341,702 | Mar 25, 07:00 PM | |
MDV | Total Purchased by All Insiders: $7,084 | |||||||
Halfacre Aaron Scott | CEO and President | Mar 25, 2024 | $15.92 | 445 | 7,084 | 75,504 | Mar 27, 01:53 PM | |
GLBZ | Total Purchased by All Insiders: $6,850 | |||||||
Hanna Mark Christopher | President and CEO | Mar 22, 2024 | $5.50 | 700 | 3,850 | 1,700 | Mar 25, 09:58 AM | |
Hanna Mark Christopher | President and CEO | Mar 14, 2024 | $6.00 | 500 | 3,000 | 2,200 | Mar 26, 10:27 AM | |
DXR | Total Purchased by All Insiders: $6,525 | |||||||
Michel Robert J | Chief Financial Officer | Mar 27, 2024 | $8.70 | 750 | 6,525 | 11,300 | Mar 27, 01:35 PM | |
PRPL | Total Purchased by All Insiders: $6,061 | |||||||
Ulrich George Turner | Principal Accounting Officer | Mar 22, 2024 | $1.52 | 4,000 | 6,061 | 16,874 | Mar 26, 08:00 AM | |
ISDR | Total Purchased by All Insiders: $6,035 | |||||||
BALBIRNIE BRIAN R | Director, CEO | Mar 22, 2024 | $12.07 | 500 | 6,035 | 619,521 | Mar 25, 04:06 PM | |
AE | Total Purchased by All Insiders: $5,406 | |||||||
Harrison Wade M | President, Service Transport | Mar 26, 2024 | $26.99 | 48 | 1,296 | 3,306 | Mar 26, 05:04 PM | |
Roycraft Kevin J. | CEO & President | Mar 26, 2024 | $27.40 | 150 | 4,110 | 9,362 | Mar 26, 05:02 PM | |
PHX | Total Purchased by All Insiders: $3,220 | |||||||
True Chad | Principal Accounting Officer | Mar 26, 2024 | $3.22 | 1,000 | 3,220 | 74,020 | Mar 26, 01:59 PM | |
BNZI | Total Purchased by All Insiders: $1,344 | |||||||
Davy Joseph P. | Chief Executive Officer | Feb 23, 2024 | $0.80 | 500 | 400 | 4,398 | Mar 26, 08:14 PM | |
Davy Joseph P. | Chief Executive Officer | Feb 22, 2024 | $0.94 | 500 | 472 | 3,898 | Mar 26, 08:14 PM | |
Davy Joseph P. | Chief Executive Officer | Feb 21, 2024 | $0.94 | 500 | 472 | 3,398 | Mar 26, 08:14 PM | |
RZLT | Total Purchased by All Insiders: $1,275 | |||||||
ROBERTS BRIAN KENNETH | Chief Medical Officer | Mar 28, 2024 | $2.55 | 500 | 1,275 | 1,076 | Mar 29, 11:08 AM | |
BCDA;BCDAW | Total Purchased by All Insiders: $195 | |||||||
Altman Peter | President and CEO | Mar 28, 2024 | $0.39 | 500 | 195 | 555,947 | Mar 28, 07:33 PM |
SYMBOL | OWNER | RELATIONSHIP | DATE | COST | # SHARES | VALUE($) | TOTAL SHARES | FILING |
ORCL | Total Sold by All Insiders: $347.82 million | |||||||
CATZ SAFRA | Chief Executive Officer | Mar 27, 2024 | $125.90 | 810,000 | 101,978,863 | 1,174,209 | Mar 27, 07:02 PM | |
CATZ SAFRA | Chief Executive Officer | Mar 26, 2024 | $126.54 | 790,000 | 99,970,313 | 1,118,592 | Mar 27, 07:02 PM | |
CATZ SAFRA | Chief Executive Officer | Mar 25, 2024 | $126.84 | 1,150,000 | 145,867,838 | 1,181,625 | Mar 27, 07:02 PM | |
META | Total Sold by All Insiders: $195.31 million | |||||||
Zuckerberg Mark | COB and CEO | Mar 27, 2024 | $494.27 | 31,493 | 15,566,156 | 29,546 | Mar 27, 08:57 PM | |
Zuckerberg Mark | COB and CEO | Mar 27, 2024 | $493.89 | 32,570 | 16,086,087 | 668,236 | Mar 27, 08:55 PM | |
Zuckerberg Mark | COB and CEO | Mar 27, 2024 | $494.07 | 12,925 | 6,385,815 | 11,725 | Mar 27, 08:55 PM | |
Zuckerberg Mark | COB and CEO | Mar 26, 2024 | $503.31 | 31,493 | 15,850,749 | 30,374 | Mar 27, 08:39 PM | |
Zuckerberg Mark | COB and CEO | Mar 26, 2024 | $502.99 | 13,125 | 6,601,687 | 12,684 | Mar 27, 08:33 PM | |
Zuckerberg Mark | COB and CEO | Mar 26, 2024 | $502.85 | 32,794 | 16,490,370 | 669,543 | Mar 27, 08:33 PM | |
Newstead Jennifer | Chief Legal Officer | Mar 26, 2024 | $505.29 | 585 | 295,595 | 39,568 | Mar 27, 08:24 PM | |
Zuckerberg Mark | COB and CEO | Mar 25, 2024 | $503.92 | 32,794 | 16,525,675 | 670,378 | Mar 27, 08:28 PM | |
Zuckerberg Mark | COB and CEO | Mar 25, 2024 | $504.20 | 31,493 | 15,878,874 | 30,893 | Mar 27, 08:28 PM | |
Zuckerberg Mark | COB and CEO | Mar 25, 2024 | $504.01 | 13,125 | 6,615,069 | 12,925 | Mar 27, 08:28 PM | |
Olivan Javier | Chief Operating Officer | Mar 22, 2024 | $507.00 | 490 | 248,430 | 9,049 | Mar 26, 06:29 PM | |
Zuckerberg Mark | COB and CEO | Mar 22, 2024 | $507.41 | 32,794 | 16,640,061 | 664,882 | Mar 25, 06:14 PM | |
Zuckerberg Mark | COB and CEO | Mar 22, 2024 | $507.43 | 31,493 | 15,980,501 | 25,739 | Mar 25, 06:14 PM | |
Zuckerberg Mark | COB and CEO | Mar 22, 2024 | $507.64 | 13,125 | 6,662,837 | 8,813 | Mar 25, 06:14 PM | |
Zuckerberg Mark | COB and CEO | Mar 21, 2024 | $509.64 | 13,125 | 6,688,961 | 12,238 | Mar 25, 06:09 PM | |
Zuckerberg Mark | COB and CEO | Mar 21, 2024 | $510.00 | 32,794 | 16,725,063 | 669,704 | Mar 25, 06:09 PM | |
Zuckerberg Mark | COB and CEO | Mar 21, 2024 | $510.12 | 31,493 | 16,065,074 | 28,862 | Mar 25, 06:09 PM | |
COP | Total Sold by All Insiders: $83.54 million | |||||||
Olds Nicholas G | Executive Vice President | Mar 25, 2024 | $126.44 | 12,150 | 1,536,280 | 14,522 | Mar 26, 04:30 PM | |
Lance Ryan Michael | Chairman and CEO | Mar 25, 2024 | $125.91 | 607,000 | 76,426,826 | 6,780 | Mar 26, 04:30 PM | |
Bullock William L. Jr. | Executive Vice President & CFO | Mar 22, 2024 | $123.32 | 45,200 | 5,574,276 | 44,153 | Mar 25, 04:10 PM | |
AZO | Total Sold by All Insiders: $59.88 million | |||||||
RHODES WILLIAM C III | Executive Chairman | Mar 26, 2024 | $3190.49 | 6,700 | 21,376,305 | 21,157 | Mar 26, 04:27 PM | |
RHODES WILLIAM C III | Executive Chairman | Mar 26, 2024 | $3187.48 | 2,800 | 8,924,952 | 24,757 | Mar 26, 04:26 PM | |
RHODES WILLIAM C III | Executive Chairman | Mar 25, 2024 | $3197.51 | 9,251 | 29,580,165 | 24,587 | Mar 26, 04:26 PM | |
MSTR | Total Sold by All Insiders: $44.44 million | |||||||
SAYLOR MICHAEL J | Executive Chairman | Mar 28, 2024 | $1927.86 | 1,027 | 1,979,909 | 927 | Mar 29, 04:05 PM | |
SAYLOR MICHAEL J | Executive Chairman | Mar 28, 2024 | $1743.88 | 3,973 | 6,928,448 | 4,900 | Mar 29, 04:04 PM | |
SAYLOR MICHAEL J | Executive Chairman | Mar 27, 2024 | $1948.55 | 1,140 | 2,221,350 | 1,040 | Mar 28, 04:10 PM | |
SAYLOR MICHAEL J | Executive Chairman | Mar 27, 2024 | $1909.70 | 3,860 | 7,371,447 | 4,900 | Mar 28, 04:09 PM | |
SAYLOR MICHAEL J | Executive Chairman | Mar 26, 2024 | $1864.11 | 5,000 | 9,320,557 | 4,900 | Mar 27, 04:25 PM | |
SAYLOR MICHAEL J | Executive Chairman | Mar 25, 2024 | $1858.03 | 809 | 1,503,143 | 790 | Mar 26, 05:21 PM | |
SAYLOR MICHAEL J | Executive Chairman | Mar 25, 2024 | $1820.08 | 1,851 | 3,368,966 | 2,531 | Mar 26, 05:17 PM | |
SAYLOR MICHAEL J | Executive Chairman | Mar 25, 2024 | $1707.48 | 2,340 | 3,995,500 | 4,961 | Mar 26, 05:13 PM | |
SAYLOR MICHAEL J | Executive Chairman | Mar 22, 2024 | $1549.19 | 5,000 | 7,745,970 | 4,700 | Mar 25, 04:51 PM | |
RDDT | Total Sold by All Insiders: $41.14 million | |||||||
Slowe Christopher Brian | Chief Technology Officer | Mar 25, 2024 | $32.30 | 185,000 | 5,975,500 | 413,684 | Mar 27, 06:32 PM | |
Huffman Steve Ladd | CEO & President | Mar 25, 2024 | $32.30 | 500,000 | 16,150,000 | 710,306 | Mar 27, 06:32 PM | |
Vollero Andrew | Chief Financial Officer | Mar 25, 2024 | $32.30 | 71,765 | 2,318,009 | 681,660 | Mar 27, 06:31 PM | |
Wong Jennifer L. | Chief Operating Officer | Mar 25, 2024 | $32.30 | 325,000 | 10,497,500 | 1,736,813 | Mar 27, 06:31 PM | |
Wong Jennifer L. | Chief Operating Officer | Mar 25, 2024 | $32.30 | 189,000 | 6,104,700 | 0 | Mar 27, 06:31 PM | |
Reynolds Michelle Marie | Chief Accounting Officer | Mar 25, 2024 | $32.30 | 3,033 | 97,966 | 96,413 | Mar 27, 06:31 PM | |
ANET | Total Sold by All Insiders: $33.42 million | |||||||
Ullal Jayshree | President and CEO | Mar 27, 2024 | $296.24 | 4,500 | 1,333,080 | 1,651,800 | Mar 29, 07:10 PM | |
Ullal Jayshree | President and CEO | Mar 27, 2024 | $296.24 | 4,500 | 1,333,080 | 1,651,800 | Mar 29, 07:10 PM | |
Ullal Jayshree | President and CEO | Mar 27, 2024 | $296.24 | 14,000 | 4,147,360 | 6,533,492 | Mar 29, 07:10 PM | |
Ullal Jayshree | President and CEO | Mar 26, 2024 | $298.97 | 4,500 | 1,345,365 | 1,656,300 | Mar 28, 07:08 PM | |
Ullal Jayshree | President and CEO | Mar 26, 2024 | $298.97 | 4,500 | 1,345,365 | 1,656,300 | Mar 28, 07:08 PM | |
Ullal Jayshree | President and CEO | Mar 26, 2024 | $298.97 | 14,000 | 4,185,580 | 6,547,492 | Mar 28, 07:08 PM | |
Ullal Jayshree | President and CEO | Mar 25, 2024 | $301.45 | 13,000 | 3,918,850 | 6,561,492 | Mar 27, 07:30 PM | |
Ullal Jayshree | President and CEO | Mar 25, 2024 | $301.45 | 4,500 | 1,356,525 | 1,660,800 | Mar 27, 07:30 PM | |
Ullal Jayshree | President and CEO | Mar 25, 2024 | $301.45 | 4,500 | 1,356,525 | 1,660,800 | Mar 27, 07:30 PM | |
Ullal Jayshree | President and CEO | Mar 22, 2024 | $303.00 | 4,500 | 1,363,500 | 1,665,300 | Mar 26, 05:35 PM | |
Ullal Jayshree | President and CEO | Mar 22, 2024 | $303.00 | 4,500 | 1,363,500 | 1,665,300 | Mar 26, 05:35 PM | |
Ullal Jayshree | President and CEO | Mar 22, 2024 | $303.00 | 13,000 | 3,939,000 | 6,574,492 | Mar 26, 05:35 PM | |
Ullal Jayshree | President and CEO | Mar 21, 2024 | $299.00 | 4,500 | 1,345,500 | 1,669,800 | Mar 25, 07:06 PM | |
Ullal Jayshree | President and CEO | Mar 21, 2024 | $299.00 | 12,500 | 3,737,500 | 6,587,492 | Mar 25, 07:06 PM | |
Ullal Jayshree | President and CEO | Mar 21, 2024 | $299.00 | 4,500 | 1,345,500 | 1,669,800 | Mar 25, 07:06 PM | |
CRM | Total Sold by All Insiders: $26.08 million | |||||||
Benioff Marc | Chair and CEO | Mar 28, 2024 | $301.37 | 15,000 | 4,520,536 | 13,034,519 | Mar 29, 04:48 PM | |
Benioff Marc | Chair and CEO | Mar 27, 2024 | $303.74 | 15,000 | 4,556,029 | 13,054,228 | Mar 28, 05:42 PM | |
Harris Parker | Co-Founder and CTO, Slack | Mar 26, 2024 | $306.60 | 4,200 | 1,287,735 | 108,681 | Mar 27, 04:54 PM | |
Millham Brian | President and COO | Mar 26, 2024 | $307.50 | 1,663 | 511,373 | 0 | Mar 27, 04:51 PM | |
Benioff Marc | Chair and CEO | Mar 26, 2024 | $306.56 | 15,000 | 4,598,340 | 13,065,936 | Mar 27, 04:46 PM | |
Reddy Sundeep G. | EVP & Chief Accounting Officer | Mar 25, 2024 | $305.46 | 66 | 20,160 | 5,911 | Mar 26, 09:11 PM | |
Harris Parker | Co-Founder and CTO, Slack | Mar 25, 2024 | $305.46 | 942 | 287,741 | 106,341 | Mar 26, 09:09 PM | |
Millham Brian | President and COO | Mar 25, 2024 | $305.46 | 1,679 | 512,863 | 2,521 | Mar 26, 09:03 PM | |
Benioff Marc | Chair and CEO | Mar 25, 2024 | $305.61 | 15,000 | 4,584,114 | 13,085,585 | Mar 26, 08:59 PM | |
Weaver Amy E | President and CFO | Mar 25, 2024 | $305.46 | 942 | 287,741 | 39,920 | Mar 26, 08:43 PM | |
Tallapragada Srinivas | Pres/Chief Engineering Officer | Mar 25, 2024 | $305.46 | 942 | 287,741 | 61,853 | Mar 26, 08:40 PM | |
Benioff Marc | Chair and CEO | Mar 22, 2024 | $308.35 | 15,000 | 4,625,214 | 13,096,231 | Mar 25, 04:48 PM | |
UTHR | Total Sold by All Insiders: $21.45 million | |||||||
ROTHBLATT MARTINE A | CHAIRPERSON & CEO | Mar 28, 2024 | $237.19 | 14,125 | 3,350,374 | 12,413 | Mar 29, 04:30 PM | |
ROTHBLATT MARTINE A | CHAIRPERSON & CEO | Mar 27, 2024 | $242.29 | 15,000 | 3,634,324 | 15,099 | Mar 29, 04:30 PM | |
ROTHBLATT MARTINE A | CHAIRPERSON & CEO | Mar 26, 2024 | $247.88 | 15,000 | 3,718,242 | 14,986 | Mar 27, 04:30 PM | |
ROTHBLATT MARTINE A | CHAIRPERSON & CEO | Mar 25, 2024 | $244.14 | 15,000 | 3,662,157 | 14,662 | Mar 27, 04:30 PM | |
ROTHBLATT MARTINE A | CHAIRPERSON & CEO | Mar 22, 2024 | $236.49 | 15,000 | 3,547,302 | 13,350 | Mar 25, 04:30 PM | |
ROTHBLATT ... |
Full story available on Benzinga.com
recession pandemic nasdaq recession chinaSpread & Containment
Unravel: The Power and Politics of Textiles in Art – Barbican show reveals the medium’s subversive nature
Textiles have a deceptive simplicity that conceals their potential for subversion and political dissent.
Textile art is having a revival, as the artists on show at the Barbican exhibition, Unravel: The Power and Politics of Textiles in Art, attest.
The show is a comprehensive journey through the themes explored by artists utilising textiles as a medium. But it also invites deeper reflection on the societal shifts that have prompted a revival of the art form. Historically associated with femininity, domesticity and craft, textiles possess a deceptive simplicity that conceals their potential for subversion and political dissent.
The exhibition focuses on this subversive nature of textiles in contemporary art through works by artists including Feliciano Centurión. His delicate floral embroideries on modest blanket squares are accompanied by poignant stitched phrases such as “Soy alma en pena” (“I am a soul in pain”) and “Estoy vivo” (“I am alive”). These words express his battle with HIV and affirm his queer masculine identity.
Małgorzata Mirga-Tas’s collaged textile hanging, meanwhile, revises historical depictions of the Romani community. In doing so, the artist reclaims space for stories excluded from historical accounts. And Igshaan Adams’s immersive ethereal installation, crafted from beads and wire structures, prompts reflection on the collective opposition to artificially imposed borders in South Africa’s apartheid regime.
The changing landscape of exhibiting textiles
The exhibition also includes works by established figures such as Sheila Hicks and Magdalena Abakanowicz. Their works were displayed in the Wall Hangings exhibition at New York’s Museum of Modern Art in 1969, a pivotal show that legitimised the use of fibre within the realm of the fine arts.
Using unorthodox and found materials, female artists of this era departed from the European tapestry tradition. Their three-dimensional fibre structures both physically and metaphorically reclaimed space in an art world largely dominated by their male counterparts.
In the catalogue for the Barbican exhibition one of the curators, Lotte Johnson, remarks: “Back in 2020, we had collectively noted how textiles were proliferating across contemporary art practices.” This proliferation can be traced back to recent societal changes, as well as the instrumental role of cultural intermediaries including museums and private galleries.
Social movements like #MeToo and Black Lives Matter have highlighted the need to tell a more inclusive history of art and acknowledge the contributions of women, people of colour and indigenous artists who have been overlooked in traditional accounts.
Further, the global spread of biennials and fairs, along with increase mobility of curators, has contributed greater visibility of artists from countries such as Africa and South America. Their practices often employ textiles and recycled elements, transcending the European dichotomy between art and craft.
The consumer demand for handmade textile items – a trend in response to an increasingly digitised society – has also played a role in the renewed appreciation for textile-based art. Additionally, movements associated with environmentalism and third-wave feminism have embraced traditionally domestic practices such as knitting and crocheting. These enjoyed further popularity during the COVID pandemic as a stress-coping mechanism.
Museums have been pivotal in endorsing the revival of textiles. And the increased prevalence of women in positions of power at cultural institutions is partly why. The retrospective on Anni Albers at the Tate Modern in 2018, for example, is much-cited as a show that put the spotlight back on textiles. The show was supported by the appointments of Frances Morris as director of Tate Modern in 2016 and Maria Balshaw as director of Tate the following year.
Additionally, a new generation of curators are shaping curatorial programmes to include a more diverse range of artistic practices. These curators were educated by feminist art history scholars such as Griselda Pollock and have now moved into influential roles within prominent art institutions.
Interest in textiles is also gaining momentum within the private art sector. According to the art market database Artprice, textile works generated US$40 million (£31.6m) in 2022, a significant increase from $13 million in 2012.
Private galleries are exerting a growing influence on the art world, and have contributed significantly to the visibility of fibre art and textiles. Last October, the private gallery Alison Jacques opened a new space in London with a solo show on Sheila Hicks. At the Brafa art fair in Brussels in January 2024, Richard Saltoun showcased Textile Pioneers, which exhibited works by Barbara Levittoux-Świderska and Magdalena Abakanowicz, among others.
While the promotion of female textile artists is certainly a welcome shift towards a more inclusive representation of historical artistic contributions, the private sector’s commercial considerations cannot be overlooked. Female artists have been defined as “the bargain of our time”, and textile works are an affordable purchase for underfunded institutions and collectors who cannot afford works by male artists from the same period.
Moreover, the practicality of textiles, being easier to transport and install compared to paintings, further enhances their appeal to galleries.
The resurgence of textiles in contemporary art provides a vital opportunity for conversation and revision within both the art world and society at large. It also highlights the complex interplay of cultural intermediaries who juggle idealistic efforts and pragmatic commercial interests.
Looking for something good? Cut through the noise with a carefully curated selection of the latest releases, live events and exhibitions, straight to your inbox every fortnight, on Fridays. Sign up here.
Francesca Stocco does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
spread pandemic africa south america europeanInternational
Why we need to rethink what we know about dust
New research reveals our understanding of dust’s role in the environment is far from settled.
You may think of dust as an annoyance to be vacuumed and disposed of, but actually, on a grander scale, it is far more important than most people realise. Globally, dust plays a critical role in regulating our climate, radiation balance, nutrient cycles, soil formation, air quality and even human health.
But our understanding of it has been hampered by limitations in current mathematical models. These models, built on methods developed decades ago, struggle to accurately simulate the properties and quantities of dust.
The latest research by my colleagues and I sheds light on these limitations and suggests a more nuanced picture of dust. Our findings reveal that dust emissions are not constant but shift seasonally and between hemispheres, across deserts and shrublands. This challenges the long-held notion that north Africa and the Middle East are the dominant sources of global dust.
Using two types of satellite data, our research suggests that dust emissions during dust storms are rare and localised, much like lightning strikes, and occur in constantly shifting locations.
Dust’s complexity
The cycle of dust emission, transport and deposition has positive and negative effects on our environment. Nutrients in deposited dust fertilise our oceans and rainforests. But dust from eroded sediment can also damage plants and trees and disrupt photosynthesis, while dust deposited on ice increases the speed at which it melts.
Variations in dust composition, like mineral type and colour, create a complex cocktail of particles injected into the atmosphere. This, in turn, interacts with clouds to influence how sunlight is reflected or absorbed, ultimately regulating Earth’s temperature.
So, it is vital we have an accurate understanding of where dust emissions are coming from, in what quantities, how dust is transported across the planet and where it ends up.
Dust emission models were developed nearly 30 years ago when there was far less data available. Consequently, those now classical dust cycle models made some assumptions. One important assumption was that Earth’s land surface was uniformly covered in perpetually loose and dry material, which was always available and caused dust emissions.
However, we now know from field measurements that soils are often crusted or covered in different types of gravel. The threshold for the wind to lift the soil and release it to the atmosphere was also assumed to be fixed and unchanging over time.
We also now know that sediment moves around the landscape and may not always be available. Vegetation covering the soil reduces the wind’s speed at reaching the soil surface, which then reduces dust emission. Dust models still assume that “greenness” indicates the presence of vegetation. However, in drylands where most dust emission happens, the vegetation is often brown, but its roughness still reduces the wind’s speed and shelters the soil from dust emission.
Consequently, classical dust cycle models have over-estimated the amount of dust emission. These weaknesses have remained since models were developed. This is mainly because modellers assume that by adjusting their dust cycle models to the measurements of dust in the atmosphere they overcome any weaknesses in the dust emission modelling.
A new approach
Almost a decade ago we developed a new approach using shadow to estimate how much of the wind’s speed is reduced by roughness, such as vegetation, on the Earth’s surface. This approach was still limited by the previous model assumptions described.
However, during the pandemic, traditional field studies became impossible. So, we adopted a new approach. Using satellites, we produced a global collection of dust emission points. This provided valuable data and paved the way for further research.
We found that existing models overestimated the role of north Africa as the primary source of global dust emissions. Our research shows that dust emissions shift seasonally and between hemispheres, from deserts in east Asia, the Middle East and north Africa as well as shrublands in Australia and North America.
Current models have only been providing a fraction of the story based on dust in the atmosphere above north Africa and the Middle East. Little dust emission was predicted to occur in the southern hemisphere. But this contrasts with field observations and the experiences of people in those regions.
These new findings are crucial for large scale models because the properties of dust are different depending on where they come from. Not only that, but dust may change as it is transported within a hemisphere to different destinations where it settles on land, in our oceans and on icecaps.
Our new understanding of dust distribution, quantity and seasonal shifts has significant implications. It will require revisions to historical reconstructions that explain past climate changes. Our findings will also influence future climate projections and how the dust cycle interacts with the carbon, energy and water cycles of Earth’s systems.
Adrian Chappell receives funding from the UK Natural Environmental Research Council (NERC).
africa uk pandemicInternational
“They Will Surely Try To Run The ‘Disease X’ Ruse” Ahead Of 2024 Elections
"They Will Surely Try To Run The ‘Disease X’ Ruse" Ahead Of 2024 Elections
Authored by James Howard Kunstler via Kunstler.com,
This Is Not…
Authored by James Howard Kunstler via Kunstler.com,
This Is Not An April Fool's Gag
“I’m sorry for the harsh message, but somebody needs to tell the truth,” virologist Dr. Geert Vanden Bossche
Did you have a fabulous Transgender Visibility Day, uncluttered with any loose talk about one Jesus Christ and his travails in the Roman Levant some 2000 years ago?
The Easter Bunny desisted from twerking on the White House lawn this time around, but the Party of Chaos still nailed down the vote of the .000429 percent of the population that identifies as opposite the clerical error made upon their sexual assignment at birth.
All in all, this may be the last grotesque frivolity the political class indulges in for a long time to come, and I’ll you why.
I had the honor of interviewing the Belgian virologist Geert Vanden Bossche on Friday for my podcast, and he had quite a sobering message.
“What I am predicting,” he said, “is a massive, massive tsunami” of illness and death among highly-vaccinated populations with dysregulated immune systems.
“You commit errors or even crimes at the very small scale, you can hide them,” he said (at around 47:00 minutes into the hour-long discussion).
“I have seen this happen with the Ebola vaccination with Africa a number of years ago. . . . However, if you do this at the very large scale, like what has happened with this mass [Covid] vaccination campaign, the truth will surface. And those who have committed these crimes who have been lying to the people, who have not been taking care of the health and safety of the people, will be severely, severely punished. . . . If these people would now go out and say, ‘Yeah, wait a minute, we have been making some mistakes, it wasn’t all right, we have to correct them, we have to revise our opinion,’ these people will be stoned in the streets. . . . They can only hope that something will happen that will distract from this issue, but it won’t. . . . The truth will surface: this has been a large-scale experiment of gain-of-function on the very human population. This will be something that will be reported in history for many many generations to come.”
A bit further on (around 55:20 minutes) he says, “You will see what will happen, for example, in the next coming weeks. . . is more and more cases of more serious long Covid..."
"They will start to replace the surge of the cancers. . . now we have a more chronic phase. It will end with a hyper-acute phase, a huge, huge wave. . . I’ve been studying this now for four years. I know what I’m talking about.
I’m probably the only person, in all modesty, who understands the immunology behind this. . . ."
(At 1:00:12) "The thing I want your audience to understand, what we will be facing in the hyper-acute Covid crisis that is imminent, is that we will have to build a completely new world. . . ."
"It is very very clear that when this starts, our hospitals will collapse. And that means the chaos in all kinds of layers of society — financial, economic, social, you name it — will be complete. And that is what I’m very clearly predicting. . . .
It’s very strange for me to make such statements, but I’m not hiding it because I’m two hundred percent convinced that it will happen.”
Now that you’ve had an ice-cold shower, consider some further implications of this scenario.
One is that the government and its public health officials may try to attribute the blame for this to the “Disease X” story they’ve been peddling for about a year, the “next pandemic,” something entirely new.
That will not be true. They will be trying to cover their asses. Rather, this next episode will be the result of the epic blunders they already made, beginning in 2020, with the emergence of Covid-19. The variant that causes the coming hyper-acute crisis will be quite different from the original “Wuhan” strain, but it will be a direct descendent of it, having mutated in the bodies of the vaccinated. It was, after all, Dr. Vanden Bossche who declared at the outset of the Covid melodrama in 2021 that vaccinating into the teeth of an ongoing pandemic disease was absolutely the wrong strategy from an immunological point-of-view, and sure to produce a grievous outcome.
What, if anything, can you do to prepare for this? Dr. Vanden Bossche is also very clear:
“What I can advise. . . to all these vaccinated people: they need to avoid reinfection. It is the reinfection of vaccinated people that is responsible for this situation. . . . Well, the only thing they can do — it’s very simple — is take anti-virals, of course. The only difference is, you will not be able to wait to take anti-virals until you have symptoms. . . .
As soon as people see that in one of the other countries, or one of the other states in the United States, when this starts with hospitalizations going up very rapidly, they need to take anti-virals prophylactically, not wait until they have any symptoms. I’m in Belgium. If it starts in the US, or starts in Israel, or starts in the UK, I bet you that within a few days, you will see the same scenario in many of the highly-vaccinated countries.”
By “anti-virals,” Dr. Vanden Bossche means specifically Ivermectin, the Nobel Prize-winning drug that the FDA and the CDC demonized brutally in order to distract the public from knowing that there was a safe and effective treatment for Covid. To acknowledge that would have vacated Pfizer’s and Moderna’s Emergency Use Authorization, which allowed them to make tens of billions of dollars on a very poorly tested pharma product while enjoying blanket protection against lawsuits.
“I have been predicting already a half a year ago, that the public health authorities are finally going to have mandates for ivermectin.” Dr. Vanden Bossche said.
“The results with ivermectin are fabulous. It is very safe. It is the only anti-viral that is cost-effective, that is widely available, that can be supplemented in sufficient quantities. . . . There is simply no alternative.”
Note that just last week, as a result of a lawsuit brought in the Texas Southern District federal court, the FDA agreed to finally take down the social media messages it had put up to lawlessly block the use of ivermectin. Remember the mocking tweet: “You’re not a horse, you’re not a cow, come on y’all.” The truth was that the FDA had no authority to tell doctors how to practice medicine; nor to block FDA-approved drugs (including ivermectin), even for off-label treatments. Off-label treatment with approved drugs is routine in medicine. Instead of ivermectin, US public health officials pushed the use of unsafe remdesivir with intubation, resulting in many thousands of avoidable deaths. This is only one of the crimes they will have to answer for.
If Dr. Vanden Bossche’s scenario comes to pass, the “hyper-acute Covid crisis” will intersect with the elections of 2024, and not just in the USA.
You would naturally expect some extreme despotic hysterics out of the “Joe Biden” government.
They will surely try to run their “Disease X” ruse. But they have already lost the trust of the people they made war against in their own country. In which case, expect resistance among the un-sick. No more trips will be laid on us.
* * *
Support his blog by visiting Jim’s Patreon Page or Substack
-
International2 weeks ago
Parexel CEO to retire; CAR-T maker AffyImmune promotes business leader to chief executive
-
Spread & Containment3 weeks ago
IFM’s Hat Trick and Reflections On Option-To-Buy M&A
-
International4 weeks ago
EyePoint poaches medical chief from Apellis; Sandoz CFO, longtime BioNTech exec to retire
-
International4 weeks ago
Walmart launches clever answer to Target’s new membership program
-
Uncategorized1 month ago
Evidence And Insights About Gold’s Long-Term Uptrend
-
Uncategorized1 month ago
A Global, Digital Coup d’État
-
Spread & Containment1 week ago
Japanese Preprint Calls For mRNA VaccinesTo Be Suspended Over Blood Bank Contamination Concerns
-
International17 hours ago
“They Will Surely Try To Run The ‘Disease X’ Ruse” Ahead Of 2024 Elections